Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have received an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $20.25.

Several brokerages recently commented on MOBI. Bank of America started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They set a “buy” rating and a $16.00 target price for the company. The Goldman Sachs Group initiated coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $31.00 price target on the stock. Wolfe Research initiated coverage on Mobia Medical in a report on Tuesday, June 2nd. They set an “outperform” rating for the company. Zacks Research raised Mobia Medical to a “hold” rating in a research report on Wednesday, June 3rd. Finally, Wall Street Zen upgraded Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th.

Mobia Medical Stock Performance

MOBI opened at $10.85 on Wednesday. Mobia Medical has a 1-year low of $10.19 and a 1-year high of $15.29. The firm has a fifty day simple moving average of $12.84. The company has a market cap of $360.75 million, a PE ratio of -0.56 and a beta of 2.84.

Mobia Medical (NASDAQ:MOBI) last released its quarterly earnings data on Thursday, June 4th. The company reported ($19.30) EPS for the quarter. The business had revenue of $12.07 million for the quarter.

Insiders Place Their Bets

In other news, CFO Nelson Bunker Curnes acquired 5,000 shares of the stock in a transaction on Tuesday, June 9th. The shares were purchased at an average price of $12.79 per share, for a total transaction of $63,950.00. Following the transaction, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This represents a 1.38% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Dana G. Jr. Mead bought 7,000 shares of the company’s stock in a transaction dated Monday, May 11th. The shares were purchased at an average cost of $15.00 per share, with a total value of $105,000.00. Following the acquisition, the director directly owned 7,000 shares of the company’s stock, valued at approximately $105,000. This represents a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 1,273,332 shares of company stock worth $19,088,930 over the last three months.